Aptamers Market | Growth, Trends and Forecasts

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

18.73 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are some of the key driving factors responsible for the growth of the aptamers market.

Numerous advantages offered by these small molecules, in comparison to established antibodies, have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate the market growth.
However, many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies had to terminate their clinical investigation during late-stage clinical studies. This factor is likely to affect the growth of this market negatively. In addition, other factors, such as low awareness about these technologies in middle- and low-income countries and inadequate regulatory structure, may hamper the overall market growth.

Scope of the Report

Aptamers are short, single-stranded DNA or RNA (ssDNA or ssRNA) molecules, which can selectively bind to a specific target, including peptides, proteins, small molecules, carbohydrates, toxins, and even live cells. Aptamers assume various shapes, owing to their tendency to form helices or single-stranded loops. These molecules are extremely versatile and are used to bind targets with high specificity and selectivity.

Type
		Nucleic Acid
		Peptide

Application
		Diagnostics
		Therapeutics
		Research and Development
		Other Applications

Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle-East and Africa
	GCC
	South Africa
	Rest of Middle-East and Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Diagnostics Segment is Expected to Witness a Healthy Growth

Appropriate diagnosis is the most crucial factor for the treatment of diseases, especially viral diseases. Over the past few years, aptamer technology has observed a significant rise in its demand and usage all across the world. It has been used in a wide range of diagnostic as well as therapeutic applications; several strategies are currently being explored, in a definitive or conclusive way, using aptamers against virus proteins. From a diagnostic point of view, aptamers are presently being designed as a bio-recognition element in a variety of diagnostic systems in order to detect viral proteins, either in the blood (serum or plasma) or in the infected cells.

To understand key trends, Download Sample Report

North America Dominates the Market and is Expected to do the Same in the Forecast Period

The North American region dominates the aptamers market due to rapid technological advancements and high investment and funding to support the development of aptamers. The United States has been the hub of all major R&D activities related to aptamers. The first aptamer therapeutic product ‘’Macugen’’ was approved in 2004 by the US FDA (United States Food and Drugs Administration).

In the country, R&D happens to be the most active area of application of aptamers. A significant proportion of demand is seen in research applications, which is also responsible for generating revenues in the market. Furthermore, the growing acceptance of personalized medicine is also one of the major factors driving the growth of the market. Aptamers have evolved rapidly in the past ten years, and aptamers have targeted a range of molecules involved in tumor progression and metastasis, present at different sites.

To understand geography trends, Download Sample Report.

Competitive Landscape

The aptamers market is highly competitive and consists of a number of major players. Companies, like AM Biotechnologies LLC, Aptagen LLC, Aptamer Sciences Inc., Aptamer Group, Aptus Biotech S.L., Base Pair Biotechnologies Inc., NOXXON Pharma, SomaLogic Inc., TriLink BioTechnologies Inc., and Vivonics Inc., among others, hold the substantial share in the aptamers market.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Advantages of Aptamers Compared to Antibodies
  2. 4.2.2 Advancements in the Field of Aptamer Technologies
  3. 4.2.3 Growing Investment by Major Companies
3. 4.3 Market Restraints
  1. 4.3.1 Unfavorable Pharmacokinetic Properties of Aptamers
  2. 4.3.2 Issues Regarding Aptamer Development
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 Type
  1. 5.1.1 Nucleic Acid
  2. 5.1.2 Peptide
2. 5.2 Application
  1. 5.2.1 Diagnostics
  2. 5.2.2 Therapeutics
  3. 5.2.3 Research and Development
  4. 5.2.4 Other Applications
3. 5.3 Geography
  1. 5.3.1 North America
    1. 5.3.1.1 United States
    2. 5.3.1.2 Canada
    3. 5.3.1.3 Mexico
  2. 5.3.2 Europe
    1. 5.3.2.1 Germany
    2. 5.3.2.2 United Kingdom
    3. 5.3.2.3 France
    4. 5.3.2.4 Italy
    5. 5.3.2.5 Spain
    6. 5.3.2.6 Rest of Europe
  3. 5.3.3 Asia-Pacific
    1. 5.3.3.1 China
    2. 5.3.3.2 Japan
    3. 5.3.3.3 India
    4. 5.3.3.4 Australia
    5. 5.3.3.5 South Korea
    6. 5.3.3.6 Rest of Asia-Pacific
  4. 5.3.4 Middle-East and Africa
    1. 5.3.4.1 GCC
    2. 5.3.4.2 South Africa
    3. 5.3.4.3 Rest of Middle-East and Africa
  5. 5.3.5 South America
    1. 5.3.5.1 Brazil
    2. 5.3.5.2 Argentina
    3. 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 AM Biotechnologies LLC
  2. 6.1.2 Aptagen LLC
  3. 6.1.3 Aptamer Sciences Inc.
  4. 6.1.4 Aptamer Group
  5. 6.1.5 Aptus Biotech S.L.
  6. 6.1.6 Base Pair Biotechnologies Inc.
  7. 6.1.7 NOXXON Pharma
  8. 6.1.8 SomaLogic Inc.
  9. 6.1.9 Baush Health
  10. 6.1.10 Maravai Lifesciences (Trilink Biotechnologies)

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments